SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors aggressively accumulate ahead of anticipated institutional partnerships and the potential passing of the Clarity Act. While some community members remain skeptical, many are focused on the project's utility in the agentic AI economy and its ongoing infrastructure integration with major financial networks.

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Unicycive Therapeutics Inc

Unicycive Therapeutics is trending as investors monitor ongoing discussions with the FDA regarding the OLC manufacturing deficiency, which the community views as a critical path toward the June 29 PDUFA date. Discussions are heavily focused on the company's ability to maintain a clear regulatory timeline while balancing cash reserves and shareholder concerns about equity dilution.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore is trending as investors react to the company's federal mandate to resume operations, setting the stage for significant production ramp-up. Community discourse is heavily focused on the high short interest and the potential for a volatile short squeeze as production milestones are met, balanced against persistent legal friction with California regulators.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Dominos is drawing significant investor attention as market participants weigh its recent earnings report, which highlighted positive domestic sales growth alongside broader industry concerns over consumer discretionary spending. The community is actively debating the stock's long-term value and competitive positioning, with many retail traders focusing on its potential for a turnaround after recent price fluctuations.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor is trending as market participants increasingly view it as a leading infrastructure project for decentralized AI, with significant community excitement surrounding institutional interest, ETF filings, and its role as a "Bitcoin of AI." While some investors voice concerns over subnet volatility and governance centralization, many are using recent price dips as accumulation opportunities, focusing on the long-term utility of its decentralized intelligence network.

The mission of the Worldcoin project is to build the world’s largest identity and financial network as a public utility, giving ownership to everyone. A key component of the Worldcoin project is the development of the foundational infrastructure that will be important for a world where AI plays an increasingly large role.  The Worldcoin system revolves around World ID, a privacy-preserving global identity network. World ID enables users to verify their humanness online while maintaining their privacy through zero-knowledge proofs.  Using World ID, individuals will be able to prove that they are a real, unique human to any platform that integrates with the protocol, including to web3 systems, social networking sites, and governmental programs. This will enable fair airdrops or token/NFT sales, provide protection against bots/sybil attacks on social media, and enable the fairer distribution of limited governmental resources. Furthermore, World ID can also enable global democratic processes and novel forms of governance (e.g., via quadratic voting), and it may eventually show a path to AI-funded UBI. The Worldcoin token (WLD), alongside World ID, will let users participate in governing the Worldcoin protocol.   To engage with the Worldcoin protocol, individuals must first download a first wallet app that supports the creation of a World ID. Users visit a physical imaging device called the Orb to get their World ID Orb-verified. Orbs are operated by a network of independent local businesses called Orb Operators. The Orb uses multispectral sensors to verify humanness and uniqueness to issue an Orb-verified World ID, with all images being promptly deleted on-device per default (absent explicit consent to Data Custody). All Orb-verified World IDs holders are entitled to claim recurring grants of free WLD tokens, subject to certain availability restrictions. The WLD token is designed as a utility token with governance properties.

Worldcoin

Worldcoin is experiencing intense community debate, driven by a mix of skepticism surrounding influencer-led market activity and optimism tied to upcoming AI integration catalysts and infrastructure development. Investors are closely monitoring the project's ability to maintain its role as an essential proof-of-humanity protocol amidst ongoing market volatility and external scrutiny.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as investors debate its role in the real-world asset (RWA) sector, balancing enthusiasm for high-profile institutional partnerships against concerns over price stagnation and long-term tokenomics. The community is actively discussing the potential for a fee switch to generate direct yield for holders while closely monitoring its technical price action amid broader crypto market volatility.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is currently a focal point for investors as it trades near 52-week lows, with the community actively debating whether it serves as a resilient defensive dividend play or a value trap amid ongoing concerns regarding menu pricing, shifting consumer habits, and management's strategic direction. While some traders are aggressively shorting the stock on daily price action, others are highlighting heavy institutional accumulation and potential upside catalysts tied to future international growth and the upcoming 2026 FIFA World Cup promotions.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Compass Pathways is trending following the FDA's decision to grant a rolling review and a Commissioner's National Priority Voucher for its COMP360 treatment, fueling intense community discussion about the company's potential as a first-mover in the psychedelic psychiatry space. Investors are closely monitoring upcoming durability data and corporate presentations as catalysts, with many weighing the firm's commercialization strategy against the backdrop of broader biotech volatility.

Story is a purpose-built layer 1 blockchain designed specifically to onramp intellectual property (IP) to the blockchain and make it programmable.  Story tokenizes any type of IP; whether that’s an idea, an image, a real world asset, a song, an AI model, an NFT or anything in-between. By embedding usage terms, attribution, and royalty agreements directly into the blockchain, Story provides a transparent, decentralized solution for IP management. This enables IP holders to protect their work, collaborate on IP seamlessly, and unlock revenue opportunities in an AI-powered economy.

Story Protocol

Story Protocol ($IP.X) is trending as traders speculate on its potential for programmable IP and AI data training, with significant discussion around its recent performance and perceived undervaluation relative to its ecosystem growth. The community remains hyper-focused on its low circulating supply and volatility, with many users debating whether it represents a long-term infrastructure play or a high-risk short-term trade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech Stocks To Add to Your Watchlist - May 6th

Danaher, Avalo Therapeutics, Vertex Pharmaceuticals, United Therapeutics, argenex, ImmunityBio, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of publicly traded companies that use biological science and technology t...

Avalo Therapeutics (NASDAQ:AVTX) Reaches New 1-Year High Following Analyst Upgrade

Avalo Therapeutics (NASDAQ:AVTX) Sets New 52-Week High Following Analyst Upgrade...

Avalo Therapeutics (NASDAQ:AVTX) Price Target Raised to $58.00

BTIG Research upped their target price on shares of Avalo Therapeutics from $40.00 to $58.00 and gave the stock a 'buy' rating in a research report on Wednesday...

This Small-Cap Biotech Stock Is Tracking A Crucial Bullish Technical Milestone – And Retail Traders Are Taking Notice

Equity

Avalo Therapeutics announced a $375 million capital raise following a positive Phase 2 trial for skin inflammation treatment.

Avalo Therapeutics Stock Jumps 33% In Pre-Market Session: Here's Why

Avalo Therapeutics Inc. rises sharply in pre-market trading following a Phase 2 trial win and a $375 million offering.read more...

AVTX Surges Over 50% After Hours as Skin Disease Drug Shows Desired Clinical Results 

Avalo was evaluating the efficacy and safety of abdakibart in adults with moderate to severe hidradenitis suppurativa across two dosing regimens.


Avalo Therapeutics (AVTX) to Release Earnings on Monday

Avalo Therapeutics (NASDAQ:AVTX) will be releasing its Q1 2026 earnings before the market opens on Monday, May 11. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-11-avalo-therapeutics-inc-stock...

Avalo Therapeutics (NASDAQ:AVTX) CFO Sells $111,886.11 in Stock

Avalo Therapeutics, Inc. (NASDAQ:AVTX - Get Free Report) CFO Christopher Ryan Sullivan sold 8,457 shares of the company's stock in a transaction on Thursday, April 30th. The stock was sold at an average price of $13.23, for a total value of $111,886.11. Following the completion of the sale, the...

Christopher Ryan Sullivan Sells 8,458 Shares of Avalo Therapeutics (NASDAQ:AVTX) Stock

Avalo Therapeutics, Inc. (NASDAQ:AVTX - Get Free Report) CFO Christopher Ryan Sullivan sold 8,458 shares of Avalo Therapeutics stock in a transaction on Wednesday, April 29th. The stock was sold at an average price of $13.09, for a total transaction of $110,715.22. Following the completion of the...

Moody Aldrich Partners LLC Buys Shares of 133,231 Avalo Therapeutics, Inc. $AVTX

Moody Aldrich Partners LLC bought a new position in shares of Avalo Therapeutics, Inc. (NASDAQ:AVTX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 133,231 shares of the c...

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Current Price	$13.10
Prev Close	$13.61
Open	$13.62
Dividend Yield	0.00%
50-Day Moving Average	$15.67
Beta	1.75
Avg. Volume	2.93M
PE Ratio	-2.25

52-Week High	$24.27
52-Week Low	$4.20
Market Capitalization	$688.61M
EPS (Annual)	-$5.84
Price to Book	4.72
Revenue Per Employee	$1,787.88

AVTXAvalo Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AVTX News